Aspire Biopharma Holdings Growth Metrics (2022-2026) | ASBP

Growth Metrics Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) 102,273.98%2.23%-93.07%-93.32%-93.34%-93.34%-66.60%-99.26%-90.27%-85.59%786.66%262.10%
Assets Growth (3y) (Quarter) -20.38%-81.21%-85.06%-79.94%-83.65%-71.36%
Assets (QoQ) (Quarter) 101,019.08%0.07%0.38%0.79%0.97%-93.22%-3.26%0.45%1.10%-66.00%1,228.15%-49.66%142.88%-45.40%442.40%
Cash & Equivalents Growth (1y) (Quarter) -49.01%-97.75%-85.00%-67.49%2,747.60%35.66%
Cash & Equivalents Growth (3y) (Quarter) 29.63%79.63%
Cash & Equivalents (QoQ) (Quarter) -6.21%-8.04%-6.73%-36.62%323.19%-58.54%-15.62%-78.04%36,964.22%
Cash from Operations Growth (1y) (Quarter) -38.65%85.86%-395.04%-167.94%-335.26%-5.97%70.39%-296.68%407.16%-807.66%-1,927.43%-122.75%-293.47%-73.48%
Cash from Operations Growth (3y) (Quarter) 173.85%-10.79%-209.75%-187.14%-195.74%-155.53%
Cash from Operations (QoQ) (Quarter) -4,878.44%97.02%-21.50%23.06%-407.69%-4.31%34.24%-24.98%-23.60%70.85%-781.05%196.78%-465.23%34.90%3.20%15.94%-227.48%
EBITDA Margin (QoQ) (Quarter) 1.56M3.76M
EBIT Growth (1y) (Quarter) -432.16%-176.98%89.42%
EBIT Margin (QoQ) (Quarter) 1.56M3.76M
EBIT (QoQ) (Quarter) -210.20%-2,229.78%-61.45%10.99%
EBT Growth (1y) (Quarter) -1,119.74%-1,257.00%79.78%
EBT Margin (QoQ) (Quarter) -5.44M17.83M
EBT (QoQ) (Quarter) -176.71%-2,576.34%-207.85%60.13%
Enterprise Value Growth (1y) (Quarter) 49.01%97.75%85.00%67.49%-2,747.60%-35.66%
Enterprise Value Growth (3y) (Quarter) -29.63%-79.63%
Enterprise Value (QoQ) (Quarter) 6.21%8.04%6.73%36.62%-323.19%58.54%15.62%78.04%-36,964.22%
EPS (Basic) Growth (1y) (Quarter) 1,467.60%5,970.52%-108.04%-23.03%-529.44%-141.10%-173.08%-377.96%-311.64%-576.58%-526.24%95.93%
EPS (Basic) Growth (3y) (Quarter) -522.96%-51.61%-232.70%-39.59%
EPS (Basic) (QoQ) (Quarter) 157.46%3,470.04%-110.28%748.41%155.07%-104.73%-57.39%-2,163.33%75.59%68.60%-175.46%-1,849.26%-154.97%87.32%
EPS (Diluted) Growth (1y) (Quarter) -576.58%-526.24%95.93%
EPS (Diluted) (QoQ) (Quarter) -175.46%-1,849.26%-154.97%87.32%
FCF Margin (QoQ) (Quarter) 3.51M1.11M
Free Cash Flow Growth (1y) (Quarter) -38.65%85.86%-395.04%-167.94%-335.26%-5.97%70.39%-296.68%407.16%-807.66%-1,927.43%-122.75%-293.47%-73.48%
Free Cash Flow Growth (3y) (Quarter) 173.85%-10.79%-209.75%-187.14%-195.74%-155.53%
Free Cash Flow (QoQ) (Quarter) -4,878.44%97.02%-21.50%23.06%-407.69%-4.31%34.24%-24.98%-23.60%70.85%-781.05%196.78%-465.23%34.90%3.20%15.94%-227.48%
Gross Margin (QoQ) (Quarter) -0.01M0.00M
Gross Profit (QoQ) (Quarter) -213.12%675.00%
Interest Coverage Ratio Growth (1y) (Quarter) -103.20%98.08%
Interest Coverage Ratio (QoQ) (Quarter) -679.23%61.66%-247.79%
Net Cash Flow Growth (1y) (Quarter) -129.46%-395.04%-167.94%99.22%119.83%85.43%97.55%-4,510.00%3,618.63%-4,019.17%56,973.59%-7,216.14%261.39%
Net Cash Flow Growth (3y) (Quarter) 29.52%-209.75%240.18%-197.49%205.99%
Net Cash Flow (QoQ) (Quarter) -106.21%-21.50%23.06%-407.69%-4.31%34.24%99.78%12,997.50%-176.66%88.94%-321.42%10,503.70%-184.91%252.77%-154.21%613.90%
Net Income Growth (1y) (Quarter) -1,114.02%-1,257.00%79.78%
Net Income (QoQ) (Quarter) -175.42%-2,576.34%-207.85%60.13%
Net Income towards Common Stockholders Growth (1y) (Quarter) -11,635.10%1,467.60%5,970.52%-108.04%-23.03%-529.44%-141.10%-212.27%-446.44%-546.16%-1,114.02%-1,257.00%79.78%
Net Income towards Common Stockholders Growth (3y) (Quarter) -824.01%-623.99%-71.53%-350.17%-96.70%
Net Income towards Common Stockholders (QoQ) (Quarter) -5,463.84%157.46%3,470.04%-110.28%748.41%155.07%-104.73%-57.39%-2,163.33%75.59%64.09%-175.42%-2,576.34%-207.85%60.13%
Net Margin (QoQ) (Quarter) -5.44M17.83M
Operating Income Growth (1y) (Quarter) -432.16%-176.98%89.42%
Operating Income (QoQ) (Quarter) -210.20%-2,229.78%-61.45%10.99%
Operating Margin (QoQ) (Quarter) 1.56M3.76M
Profit After Tax Growth (1y) (Quarter) 295,484.64%3,370.60%1,401.18%-106.43%-106.77%-108.04%-105.35%-212.27%-407.39%-6,801.90%-1,944.19%-755.64%-514.82%79.78%
Profit After Tax Growth (3y) (Quarter) -904.71%-466.20%-164.08%-54.92%-60.19%-46.15%
Profit After Tax (QoQ) (Quarter) -11,532.58%237.42%792.53%107.03%28.80%-36.92%-103.82%-117.90%-53.05%58.04%-123.13%-254.05%-1,981.90%87.57%6.60%-154.40%31.54%
Return on Assets Growth (1y) (Quarter) 13.00
Return on Assets (QoQ) (Quarter) 5.000.00M-3.0011.00
Return on Capital Employed (QoQ) (Quarter) 0.02M-0.22M
Return on Sales (QoQ) (Quarter) -544.000.00M
Revenue (QoQ) (Quarter) 119.53%565.41%
Share-based Compensation Growth (1y) (Quarter) -100.00%
Share-based Compensation (QoQ) (Quarter) -200.00%142.90%
Total Debt Growth (1y) (Quarter) 16,385.91%14.90%-41.65%-11.24%-31.66%0.00%
Total Debt (QoQ) (Quarter) 1,654.13%96.93%524.17%-23.54%-87.77%0.00%849.49%-41.13%-82.11%